title: Capillary zone electrophoresis for determination of vildagliptin (a DPP-4 inhibitor) in pharmaceutical formulation and comparative study with HPLC.
abstract: A stability-indicating capillary zone electrophoresis (CZE) method was validated for the determination of vildagliptin (VLG) in pharmaceutical dosage forms using ranitidine hydrochloride (RH) as internal standard. The CZE method was carried out in a fused silica capillary (64.5 cm total length and 56.0 cm effective length, 50 microm i.d.) by applying a potential of 25 kV (positive polarity), hydrodynamic injection by 50 mbar for 5 s and the temperature of the capillary cartridge was 25 degreesC. The selected background electrolyte (BGE) consisted of 25 mM potassium phosphate (pH 8.0) with UV/PDA detection at 207 nm. The electrophoretic separation was obtained within 6 min and was linear in the range of 50-200 microg/mL (r= 0.9994). The specificity and the stability-indicating capability were demonstrated through degradation studies, which also showed that there was no interference of the formulation excipients. The method was validated in accordance to ICH guidelines acceptance criteria for specificity, linearity, precision, accuracy, robustness and system suitability. The proposed method was compared with HPLC method previously validated for this drug, and statistical analysis showed no significant difference between the methods.
authors.forename: A T
authors.initials: AT
authors.lastname: Barden
authors.forename: B L
authors.initials: BL
authors.lastname: Piccoli
authors.forename: N M
authors.initials: NM
authors.lastname: Volpato
authors.forename: E E S
authors.initials: EE
authors.lastname: Schapoval
authors.forename: M
authors.initials: M
authors.lastname: Steppe
mesh_terms: D000218:Adamantane / Q000031:analogs & derivatives* / Q000032:analysis; D002626:Chemistry, Pharmaceutical; D002851:Chromatography, High Pressure Liquid; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000032:analysis*; D019075:Electrophoresis, Capillary; D007202:Indicators and Reagents; D057230:Limit of Detection; D009570:Nitriles / Q000032:analysis*; D011759:Pyrrolidines / Q000032:analysis*; D012015:Reference Standards; D015203:Reproducibility of Results; D012996:Solutions; D013607:Tablets; D000077597:Vildagliptin
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D007202:Indicators and Reagents; D009570:Nitriles; D011759:Pyrrolidines; D012996:Solutions; D013607:Tablets; D000077597:Vildagliptin; D000218:Adamantane